Epidemiology of triple-negative breast cancer: a review

FM Howard, OI Olopade - The Cancer Journal, 2021 - journals.lww.com
Triple-negative breast cancer accounted for 12% of breast cancers diagnosed in the United
States from 2012 to 2016, with a 5-year survival 8% to 16% lower than hormone receptor …

Contrast‐enhanced MRI for breast cancer screening

RM Mann, CK Kuhl, L Moy - Journal of Magnetic Resonance …, 2019 - Wiley Online Library
Multiple studies in the first decade of the 21st century have established contrast‐enhanced
breast MRI as a screening modality for women with a hereditary or familial increased risk for …

Breast cancer screening for women at higher-than-average risk: updated recommendations from the ACR

DL Monticciolo, MS Newell, L Moy, CS Lee… - Journal of the American …, 2023 - Elsevier
Early detection decreases breast cancer death. The ACR recommends annual screening
beginning at age 40 for women of average risk and earlier and/or more intensive screening …

Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline☆

C Sessa, J Balmaña, SL Bober… - Annals of …, 2023 - annalsofoncology.org
Hereditary breast and ovarian cancer syndrome (HBOC) is clinically defined by family
history criteria, and molecularly defined by identification of germline pathogenic variants …

A review on methods for diagnosis of breast cancer cells and tissues

Z He, Z Chen, M Tan, S Elingarami, Y Liu, T Li… - Cell …, 2020 - Wiley Online Library
Breast cancer has seriously been threatening physical and mental health of women in the
world, and its morbidity and mortality also show clearly upward trend in China over time …

Updated breast cancer surveillance recommendations for female survivors of childhood, adolescent, and young adult cancer from the International Guideline …

RL Mulder, MM Hudson, S Bhatia, W Landier… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE As new evidence is available, the International Late Effects of Childhood Cancer
Guideline Harmonization Group has updated breast cancer surveillance recommendations …

Pregnancy and breast cancer: pathways to understand risk and prevention

PF Slepicka, SL Cyrill, CO Dos Santos - Trends in molecular medicine, 2019 - cell.com
Several studies have made strong efforts to understand how age and parity modulate the
risk of breast cancer. A holistic understanding of the dynamic regulation of the …

Magnetic resonance imaging in screening of breast cancer

Y Gao, B Reig, L Heacock, DL Bennett… - Radiologic …, 2021 - radiologic.theclinics.com
Magnetic Resonance Imaging in Screening of Breast Cancer - Radiologic Clinics Skip to Main
Content Advertisement Radiologic Clinics Log in Register Log in Subscribe Claim Skip menu …

Identification of BRCA1/2 mutation female carriers using circulating microRNA profiles

K Elias, U Smyczynska, K Stawiski, Z Nowicka… - Nature …, 2023 - nature.com
Identifying germline BRCA1/2 mutation carriers is vital for reducing their risk of breast and
ovarian cancer. To derive a serum miRNA-based diagnostic test we used samples from 653 …

Tumor contrast enhancement and whole-body elimination of the manganese-based magnetic resonance imaging contrast agent Mn-PyC3A

DJ Erstad, IA Ramsay, VC Jordan, M Sojoodi… - Investigative …, 2019 - journals.lww.com
Objectives The goals of this study were to compare the efficacy of the new manganese-
based magnetic resonance imaging (MRI) contrast agent Mn-PyC3A to the commercial …